Cargando…
Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial
OBJECTIVES: To evaluate the morphine-sparing effects of the sequential treatment versus placebo in subjects undergoing total knee arthroplasty (TKA), the effects on pain relief, inflammation control and functional rehabilitation after TKA and safety. DESIGN: Double-blind, pragmatic, randomised, plac...
Autores principales: | Zhuang, Qianyu, Tao, Liyuan, Lin, Jin, Jin, Jin, Qian, Wenwei, Bian, Yanyan, Li, Yulong, Dong, Yulei, Peng, Huiming, Li, Ye, Fan, Yu, Wang, Wei, Feng, Bin, Gao, Na, Sun, Tiezheng, Lin, Jianhao, Zhang, Miaofeng, Yan, Shigui, Shen, Bin, Pei, Fuxing, Weng, Xisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955469/ https://www.ncbi.nlm.nih.gov/pubmed/31924632 http://dx.doi.org/10.1136/bmjopen-2019-030501 |
Ejemplares similares
-
Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial
por: Zhuang, Qianyu, et al.
Publicado: (2016) -
Correction: Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial
Publicado: (2020) -
Glucocorticoid Receptor and Sequential P53 Activation by Dexamethasone Mediates Apoptosis and Cell Cycle Arrest of Osteoblastic MC3T3-E1 Cells
por: Li, Hui, et al.
Publicado: (2012) -
Comparison of intra-articular injection of parecoxib vs oral administration of celecoxib for the clinical efficacy in the treatment of early knee osteoarthritis
por: Lu, Lu, et al.
Publicado: (2019) -
Total hip/knee arthroplasty in the treatment of tumor-induced osteomalacia patients: More than 1 year follow-up
por: Zhu, Wei, et al.
Publicado: (2017)